Literature DB >> 18477705

Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.

Christos Tikellis1, Merlin C Thomas, Brooke E Harcourt, Melinda T Coughlan, Josepha Pete, Katarzyna Bialkowski, Adeline Tan, Angelika Bierhaus, Mark E Cooper, Josephine M Forbes.   

Abstract

A diet high in fat induces cardiac hypertrophy, inflammation, and oxidative stress. Although such actions have largely been ascribed to fat deposition, the accumulation of advanced glycation end products (AGEs) and subsequent activation of the receptor for AGEs (RAGE) may also represent important mediators of cardiac injury following exposure to a Western diet. In this study, male C57BL6J and RAGE knockout mice were placed on either a standard diet (7% fat) or a Western "fast-food" diet (21% fat). Animals receiving a high-fat diet were further randomized to receive the AGE inhibitor alagebrium chloride (1 mg.kg(-1).day(-1)) and followed for 16 wk. A Western diet was associated with cardiac hypertrophy, inflammation, mitochondrial-dependent superoxide production, and cardiac AGE accumulation in wild-type mice. Although RAGE-KO mice fed a Western diet also became obese and accumulated intramyocardial lipid, cardiomyocyte hypertrophy, inflammation, and oxidative stress were attenuated compared with wild-type mice. Similarly, mice of both strains receiving alagebrium chloride had reduced levels of inflammation and oxidative stress, in association with a reduction in cardiac AGEs and RAGE. This study suggests that AGEs represent important mediators of cardiac injury associated with a Western fast-food diet. These data point to the potential utility of AGE-reducing strategies in the prevention and management of cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477705      PMCID: PMC2652498          DOI: 10.1152/ajpendo.00024.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  33 in total

1.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Authors:  Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

2.  Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.

Authors:  W A Ng; I L Grupp; A Subramaniam; J Robbins
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

Review 3.  Heme oxygenase and the cardiovascular-renal system.

Authors:  Nader G Abraham; Attallah Kappas
Journal:  Free Radic Biol Med       Date:  2005-03-30       Impact factor: 7.376

4.  Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.

Authors:  T J Berg; O Snorgaard; J Faber; P A Torjesen; P Hildebrandt; J Mehlsen; K F Hanssen
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

5.  Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats.

Authors:  D M Ouwens; C Boer; M Fodor; P de Galan; R J Heine; J A Maassen; M Diamant
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

6.  High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus.

Authors:  Asli F Ceylan-Isik; Shan Wu; Qun Li; Shi-Yan Li; Jun Ren
Journal:  J Appl Physiol (1985)       Date:  2005-09-15

7.  Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.

Authors:  B Corman; M Duriez; P Poitevin; D Heudes; P Bruneval; A Tedgui; B I Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 8.  Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects.

Authors:  Jaime Uribarri; Weijing Cai; Oana Sandu; Melpomeni Peppa; Teresia Goldberg; Helen Vlassara
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

9.  Interactions between renin angiotensin system and advanced glycation in the kidney.

Authors:  Merlin C Thomas; Christos Tikellis; Wendy M Burns; Katarzyna Bialkowski; Zemin Cao; Melinda T Coughlan; Karen Jandeleit-Dahm; Mark E Cooper; Josephine M Forbes
Journal:  J Am Soc Nephrol       Date:  2005-08-17       Impact factor: 10.121

10.  Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.

Authors:  Philipp Ehlermann; Kai Eggers; Angelika Bierhaus; Patrick Most; Dieter Weichenhan; Johannes Greten; Peter P Nawroth; Hugo A Katus; Andrew Remppis
Journal:  Cardiovasc Diabetol       Date:  2006-03-30       Impact factor: 9.951

View more
  39 in total

Review 1.  The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.

Authors:  Weidun Alan Guo; Paul R Knight; Krishnan Raghavendran
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

Review 2.  Targeting advanced glycation with pharmaceutical agents: where are we now?

Authors:  Danielle J Borg; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-07-09       Impact factor: 2.916

Review 3.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 4.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

Review 5.  AGE restriction in diabetes mellitus: a paradigm shift.

Authors:  Helen Vlassara; Gary E Striker
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

Review 6.  Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Authors:  Claudia Luévano-Contreras; Armando Gómez-Ojeda; Maciste Habacuc Macías-Cervantes; Ma Eugenia Garay-Sevilla
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

7.  Effect of high advanced glycation end-product diet on pulmonary inflammatory response and pulmonary function following gastric aspiration.

Authors:  Weidun Alan Guo; Bruce A Davidson; Julie Ottosen; Patricia J Ohtake; Krishnan Raghavendran; Barbara A Mullan; Merril T Dayton; Paul R Knight
Journal:  Shock       Date:  2012-12       Impact factor: 3.454

8.  Effect of dietary fat and sucrose consumption on cardiac fibrosis in mice and rhesus monkeys.

Authors:  Niranjana Natarajan; Ana Vujic; Jishnu Das; Annie C Wang; Krystal K Phu; Spencer H Kiehm; Elisabeth M Ricci-Blair; Anthony Y Zhu; Kelli L Vaughan; Ricki J Colman; Julie A Mattison; Richard T Lee
Journal:  JCI Insight       Date:  2019-09-19

9.  An advanced glycation end product (AGE)-receptor for AGEs (RAGE) axis restores adipogenic potential of senescent preadipocytes through modulation of p53 protein function.

Authors:  Chih-Yu Chen; Allison Martorano Abell; Yang Soo Moon; Kee-Hong Kim
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

10.  Dietary fatty acids alter left ventricular myocardial gene expression in Wistar rats.

Authors:  Kimberly M Jeckel; Gerrit J Bouma; Ann M Hess; Erin B Petrilli; Melinda A Frye
Journal:  Nutr Res       Date:  2014-07-18       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.